Alogliptin benzoate is primarily used in the management of type 2 diabetes mellitus. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps regulate blood sugar levels by increasing the release of insulin and decreasing the production of glucose in the liver. This medication is often prescribed when lifestyle changes such as diet and exercise are not sufficient to control blood sugar levels. It can be used alone or in combination with other antidiabetic agents like metformin, sulfonylureas, or insulin to achieve better glycemic control. Alogliptin benzoate is particularly beneficial for patients who require a treatment option with a lower risk of hypoglycemia compared to some other diabetes medications. It is administered orally, making it convenient for long-term use. Regular monitoring of blood sugar levels is recommended to ensure its effectiveness and to adjust the treatment plan as needed.